The prenatal success of gene editing paves the way for the treatment of congenital diseases in the uterus

As part of a remarkable proof-of-principle study, scientists from the University of Pennsylvania and the Children's Hospital of Philadelphia have, for the first time, successfully used CRISPR genetic modification technology in mice in utero metabolic disorder.